Smith P - Search Results

1

Nevirapine concentrations in preterm and low birth weight HIV-exposed infants: implications for dosing recommendations.

de Waal R, Kroon SM, Holgate SL, Horn AR, Tooke LJ, Norman J, Smith P, Blockman M, Cotton MF, McIlleron HM, Cohen K. de Waal R, et al. Among authors: smith p. Pediatr Infect Dis J. 2014 Dec;33(12):1231-3. doi: 10.1097/INF.0000000000000453. Pediatr Infect Dis J. 2014. PMID: 24945881

2

Pyrazinamide plasma concentrations in young children with tuberculosis.

McIlleron H, Willemse M, Schaaf HS, Smith PJ, Donald PR. McIlleron H, et al. Pediatr Infect Dis J. 2011 Mar;30(3):262-5. doi: 10.1097/inf.0b013e3181fbefe1. Pediatr Infect Dis J. 2011. PMID: 21416694

3

Trough lopinavir concentrations in preterm HIV-infected infants.

Holgate SL, Rabie H, Smith P, Cotton MF. Holgate SL, et al. Among authors: smith p. Pediatr Infect Dis J. 2012 Jun;31(6):602-4. doi: 10.1097/INF.0b013e31825046ae. Pediatr Infect Dis J. 2012. PMID: 22414907

4

Bioequivalence of dispersed stavudine: opened versus closed capsule dosing.

Innes S, Norman J, Smith P, Smuts M, Capparelli E, Rosenkranz B, Cotton M. Innes S, et al. Among authors: smith p. Antivir Ther. 2011;16(7):1131-4. doi: 10.3851/IMP1876. Antivir Ther. 2011. PMID: 22024529 Free PMC article. Clinical Trial.

5

Effect of rifampicin on efavirenz pharmacokinetics in HIV-infected children with tuberculosis.

Ren Y, Nuttall JJ, Eley BS, Meyers TM, Smith PJ, Maartens G, McIlleron HM. Ren Y, et al. J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):439-43. doi: 10.1097/QAI.0b013e31819c33a3. J Acquir Immune Defic Syndr. 2009. PMID: 19223781 Clinical Trial.

6

Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines.

McIlleron H, Willemse M, Werely CJ, Hussey GD, Schaaf HS, Smith PJ, Donald PR. McIlleron H, et al. Clin Infect Dis. 2009 Jun 1;48(11):1547-53. doi: 10.1086/598192. Clin Infect Dis. 2009. PMID: 19392636

7

Lopinavir exposure is insufficient in children given double doses of lopinavir/ritonavir during rifampicin-based treatment for tuberculosis.

McIlleron H, Ren Y, Nuttall J, Fairlie L, Rabie H, Cotton M, Eley B, Meyers T, Smith PJ, Merry C, Maartens G. McIlleron H, et al. Antivir Ther. 2011;16(3):417-21. doi: 10.3851/IMP1757. Antivir Ther. 2011. PMID: 21555825

8

Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines.

McIlleron H, Rustomjee R, Vahedi M, Mthiyane T, Denti P, Connolly C, Rida W, Pym A, Smith PJ, Onyebujoh PC. McIlleron H, et al. Among authors: smith pj. Antimicrob Agents Chemother. 2012 Jun;56(6):3232-8. doi: 10.1128/AAC.05526-11. Epub 2012 Mar 12. Antimicrob Agents Chemother. 2012. PMID: 22411614 Free PMC article.

9

High prevalence of subtherapeutic plasma concentrations of efavirenz in children.

Ren Y, Nuttall JJ, Egbers C, Eley BS, Meyers TM, Smith PJ, Maartens G, McIlleron HM. Ren Y, et al. J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):133-6. doi: 10.1097/QAI.0b013e31805c9d52. J Acquir Immune Defic Syndr. 2007. PMID: 17417100 Clinical Trial.

10

Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis.

Cohen K, van Cutsem G, Boulle A, McIlleron H, Goemaere E, Smith PJ, Maartens G. Cohen K, et al. J Antimicrob Chemother. 2008 Feb;61(2):389-93. doi: 10.1093/jac/dkm484. Epub 2007 Dec 19. J Antimicrob Chemother. 2008. PMID: 18096560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,140 results

Search Page

Filters